Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients

10Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Isoniazid treatment of latent tuberculosis infection (LTBI) is commonly prescribed in refugees and immigrants. We aimed to assess understanding of information provided about LTBI, its treatment and potential side effects. Methods. A questionnaire was administered in clinics at a tertiary hospital. Total Knowledge (TKS) and Total Side Effect Scores (TSES) were derived. Logistic regression analyses were employed to correlate socio-demographic factors with knowledge. Results: Fifty-two participants were recruited, 20 at isoniazid commencement and 32 already on isoniazid. The average TKS were 5.04/9 and 6.23/9 respectively and were significantly associated with interpreter use. Approximately half did not know how tuberculosis was transmitted. The average TSES were 5.0/7 and 3.5/7 respectively, but were not influenced by socio-demographic factors. Conclusions: There was suboptimal knowledge about LTBI. Improvements in health messages delivered via interpreters and additional methods of distributing information need to be developed for this patient population. © 2013 Butcher et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Butcher, K., Biggs, B. A., Leder, K., Lemoh, C., O’Brien, D., & Marshall, C. (2013). Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients. BMC Research Notes, 6(1). https://doi.org/10.1186/1756-0500-6-342

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free